Gordian Surgical

The Gordian TroClose™ 1200 developed by Gordian Surgical™ is a novel integrated port closure system. 

The Product & Advantages

The TroClose 1200 offers surgeons a simple, secure, and safe solution to open and close the abdominal wall during laparoscopic procedures.

Instead of inserting closure sutures in the fascia at the end of a procedure, the TroClose 1200’s uniquely designed “two-in-one” port closure system efficiently inserts sutures into the tissue surrounding the cannula at the beginning of the procedure. When the cannula is removed, the surgeon closes the fascia by simply tying the TroClose 1200 sutures together.

  • Safe: reduced risk of organ damage
  • Simple: requires only minimal training
  • Saves time: up to 20 minutes per operation

Gordian’s TroClose 1200 can be adapted to all types of trocars: bladed/bladeless, disposable/multiuse, and others.

Gordian Surgical CEO Zvika Peer takes time out before his presentations at the China-Israel Technology Innovation Cooperation Forum, Shenzhen and Hebei, 20 May.

Gordian Surgical CEO Zvika Peer takes time out before his presentations at the China-Israel Technology Innovation Cooperation Forum, Shenzhen and Hebei, 20 May 2018.

The Team

  • Zvi Peer, CEO: Serial entrepreneur with over 20 years’ experience in medical devices and biotechnology; co-founder and CEO, Romtec Electronics (successful IPO and exit); co-founder and CEO of biotech companies Fulcrum SP and BioGroup Technology (exit); CEO, QRay, a light therapy medical device company
  • Leo R. Mindick, Chairman: Founder and CEO, Med-Tech Consultant Partners; years of experience in specialty medical devices, IP, regulatory, reimbursement; founder and former CEO multi-million-dollar specialty medical distribution company (later acquired)
  • Nissim Geron, MD, Medical Director: Head of Surgery Department, Poriya Medical Center, Israel; vast experience in laparoscopic procedures
  • Amir Schvartzer, Project Manager: Biomedical engineer with over 9 years’ experience in laparoscopic devices, including R&D, QA/RA, training, support
  • Stav Ben Shahar, COO: Engineer with more than 8 years’ experience in operations and logistics at HP Indigo and Lumenis; BSc, engineering, Ben-Gurion University of the Negev
  • Ofer Arnold, VP R&D: 18+ years of mechanical design, project management, and team leadership in the medical device sector. Previously, Director of Mechanical Engineering at XACT Robotics; managed the mechanical team at Medingo; BSc, mechanical engineering, Technion-Israel Institute of Technology

Trendlines’ directors: Todd Dollinger, Barak Singer

Scientific Advisory Board

  • Hien T. Nguyen, MD: Director, Comprehensive Hernia Center, and Assistant Professor of Surgery, Johns Hopkins University School of Medicine; Assistant Professor, Biomedical Engineering; Associate Medical Director, Center for Bioengineering Innovation and Design (CBID) School of Engineering, Johns Hopkins University
  • Edward H. Phillips, MD: Vice Chair and Professor, Department of Surgery; Director, Division of General Surgery, Storz Chair in MIS, Cedars-Sinai Medical Center; developed the laparoscopic technique of common bile duct exploration, laparoscopic splenectomy, and nipple ductoscopy
  • Barry Salky, MD: Early adopter and pioneer of therapeutic laparoscopic surgery, primary focus: MIS of the GI tract with special interest in inflammatory bowel disease; Professor of Surgery, Mount Sinai Health System; originated the Division of Laparoscopic Surgery; current Secretary, SAGES Foundation; President of the International Federation of Surgical Endoscopic Societies (IFSES)
  • Steve Schwaitzberg, MD: Professor and Chairman, Department of Surgery, University of Buffalo School of Medicine and Biomedical Sciences; past president, SAGES
  • Steven D. Wexner, MD, PhD, FACS:  Director, Digestive Disease Center; Chairman, Department of Colorectal Surgery, Cleveland Clinic-Florida; past president, SAGES and American Society of Colon and Rectal Surgeons (ASCRS), regent, ACS
  • Natan Zundel, MD, FACS: Vice-Chairman of the Department of Surgery at Florida International University, Herbert Wertheim College of Medicine in Florida; Surgeon at the Bariatric and Metabolic Institute at Jackson North Medical Center in Miami; Consultant for Minimally Invasive and Bariatric Surgery of Fundación Santa Fe de Bogotá, Colombia.


Founded: November 2012
Stage: Revenue
Investors: The Trendlines Group, B. Braun, private investment funds (China and Canada), private investors, including key opinion leaders (surgeons)
IP: 3 U.S. patents; one provisional, one in National phase
Regulatory: FDA and CE clearance; clearance in Israel and Mexico
Distribution: 6 agreements (U.K., France, Turkey, Greece, Mexico, Panama), monthly shipments; other agreements in negotiation

Recent Developments

  • Q1 2018: Increased usage of the Gordian TroClose 1200 to >250 in more than 75 hospitals (including procedures in urology robotics, general surgery robotics, bariatric, gynecology, hernia repair)
  • Initiate direct sales in the United States beginning Q2 2018

Timeline of Achievements

  • Making monthly shipments and more agreements in negotiations
  • TroClose 1200 has been used in nearly 200 procedures worldwide (as of 30 September 2017)
  • June 2017: Performed over 120 surgeries with the Gordian port-closure system
  • May 2017: Signed five distribution agreements (Mexico, Panama, UK, France, Turkey) and began sales of its TroClose1200
  • March 2017: Received its first purchase order from a European distributor
  • January 2017: Thirteen U.S. surgeons completed 17 successful procedures in January using the Gordian Surgical system, marking the first time the system had been used in the United States; bringing total number of surgeries to nearly 75; procedures were performed at a number of U.S. hospitals, including Mount Sinai in New York and Cleveland Clinic in Ohio and Florida
  • December 2016: TroClose1200 receives FDA clearance
  • December 2016: Gordian raises more than $2 million
  • September 2016: TroClose1200 receives CE mark
  • April 2016: Successful first in human, clinical trials in 3 sites (Israel, India)
  • Completed Round A investment

In the Media

Background & Market

An estimated 10 million laparoscopic procedures are performed annually. While laparoscopic surgeries are less invasive, closing abdominal access ports remains a difficult and time-consuming task. Today, surgeons manually suture ports with a needle and thread, adding up to 20 minutes per operation. Some surgeons use a dedicated closure device, rather than needle and thread, adding significantly to procedure cost and presenting safety problems.

The global trocar and closure markets are estimated at a combined US$1.45 billion yearly revenue (Medical Market and Technology Reports, MeddeviceTracker). According to MarketStrat, J&J dominates the trocar market (50%), followed by Covidien (30%) and Applied Medical (15%).


Marketing Director Doni Mayerfeld interviewed on ILTV.

CEO Zvi Peer presents at Trendlines 7th Annual Company Showcase in 2017.

See the company 1-page description in Chinese (PDF).

Gordian Surgical presentation.
See the Gordian presentation (PDF).


Zvi Peer, CEO
U.S.: +1.619.GORDIAN (467.3426)

Gordian logo

Font Resize